l carnitine effects on liver Putative role of BCAA and l-carnitine treatments in cirrhotic liver. A Carnitine Deficiency: What Is It,

Wherry EJ, Ha SJ, Kaech SM, Haining WN, Sarkar S, Kalia V, et al

10.3390/molecules19022390 172 YangJ.XuJ.LiangS

He is the Director of Prosthetic Urology and Mens Sexual Health and the Director of the UCA Fellowship in Mens Sexual Health

The analysis found low doses were as effective as full doses for preventing recurrent VTEs, but low-dose DOAC therapy reduced the risks of major and clinically relevant non-major bleeding events compared with full-dose therapy, with no significant differences between apixaban and rivaroxaban

Taieb, F., Petit, C., Nougayrde, J.-P

The main cause of hyperhomocysteinemia is a redox imbalance leading to oxidative stress characterized by an accumulation of oxidized GSH followed by an impairment of cellular integrity and kidney homeostasis